QR-koodi

Successful conversion surgery for locally advanced gallbladder cancer after gemcitabine and nab-paclitaxel chemotherapy

ObjectiveGallbladder cancer (GBC) is highly malignant and is often diagnosed at the advanced stage. Lack of opportunity to surgery results in an unsatisfactory outcome. This pilot study employed gemcitabine combined with nab-paclitaxel (AG) as a conversion therapeutic measure for locally advanced GB...

Täydet tiedot

Tallennettuna:
Päätekijät: Ziyi Yang, Ziyou Wu, Yichen Xiong, Shilei Liu, Chen Cai, Ziyu Shao, Yidi Zhu, Xiaoling Song, Wei Shen, Xuefeng Wang, Xiangsong Wu, Wei Gong
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Frontiers Media S.A. 2022-08-01
Sarja:Frontiers in Oncology
Aiheet:
gallbladder cancer
resectability
gemcitabine
nab-paclitaxel
conversion therapy
Linkit:https://www.frontiersin.org/articles/10.3389/fonc.2022.977963/full
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia